Other languages ImmuCell Corporation

Equities

ICCC

US4525253062

Market Closed - Nasdaq Other stock markets 02:00:01 15/05/2024 am IST			5-day change	1st Jan Change
5.476 ^USD	+3.92%		+7.17%	+7.59%

09/04	Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	CI
02/04	ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	02/04
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
ImmuCell Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11
ImmuCell Corporation Appoints Bryan K. Gathagan to Board of Directors	22/23/22
ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22
Immucell Corporation Provides Earnings Guidance for First Quarter Ending March 31, 2023	22/23/22
David S. Cunningham Intends to Retire from the Board of Directors of David S. Cunningham	02/23/02
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22
Immucell Corporation Enters into A Second Amendment to Its Lease from Tvp, Llc of Falmouth, Maine for Property At 175 Industrial Way in Portland	18/22/18
ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain	28/22/28
ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13
Mark Wustenberg, DVM Joins Sales and Marketing Team as Commercial Leader of Stakeholder Engagement of ImmuCell Corporation	05/22/05
ImmuCell Sees Q1 Revenue Up 46% from Year Ago	12/22/12
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23
ImmuCell Projects Record 2021 Sales	05/22/05
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ImmuCell Corporation

Equities

ICCC

US4525253062

Other languages

Filters